Rhofade wins Allure’s `Breakthrough Product’ Award


Rhofade has achieved some publicity through an award from Allure, the well known beauty magazine brand. The award is called the Allure Beauty Breakthrough Award and was  given for `making great strides in educating media and consumers about ongoing facial redness due to rosacea’.

Rhofade seems to be generally liked by rosacea sufferers – see Rhofade User Reviews for more information.

Award Commentary

Rhofade cream, 1%

More than 14 million — million — Americans have rosacea, the skin condition marked by chronic flushing and acne-like bumps. So you’d think we’d know how to treat it by now, but nope — not that easy.

There are plenty of options to help calm inflammation, but they don’t address the other cause of the redness: dilated blood vessels under the skin, says Heather Woolery-Lloyd, a dermatologist in Miami. And any prescription cream that can constrict those vessels comes with an asterisk: “After a few days of use, the flush can return, sometimes stronger than before,” says Woolery-Lloyd.

That makes Rhofade cream, 1%, the first cream to treat the flushing, full stop. The prescription formula tightens only specific blood vessels near the surface of the skin, so there’s very little risk of worsening the problem; other prescription creams can backfire and dilate blood vessels, making redness more pronounced.

Rhofade’s active ingredient, oxymetazoline hydrochloride, is the same drug found in Afrin, but in a prescription-strength concentration and combined with oils that help it penetrate the skin (a much trickier feat than getting through nasal membranes).

According to two company-sponsored clinical trials that tested thousands of patients, after 29 days of regular use, Rhofade erases redness minutes after application for up to 12 hours.

When tested daily on 440 subjects for a full year, less than 2 percent of patients saw their flushing come back; with past prescription rosacea treatments, that number was between 10 and 20 percent, according to a study published in the Journal of Drugs in Dermatology. And these aren’t just impressive numbers. They’re life-changing ones. “The flushing can be embarrassing and traumatic,” says Ellen Marmur, a dermatologist in New York City.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

4 Reader Comments

  1. Some comments from the facebook post.

    “It’s no breakthrough”

    “Did nothing for me”

    “It has worked for me..but I use it sparingly.”

    “I use this on special occasions and I love it! A little goes a long way.”

    “Is this as bad as Mirvaso for rebound??”

    “Speaking of rebound trouble, anything that is a steroid sent me down an awful path, actually turned into a fungus, just awful. After about 4 months of treatment with Oracea, Plus a Fungus cream and Edidel, I am on the road to recovery.”

    “I love it. Been using it for almost a year. Still have some redness that I can feel but most of the time people around me say they can’t see it. Better than anything else I’ve tried!”

    • Tom says:

      Sounds like someone from Rhofade quickly adds a fake news response to a legitimate comment about product not working. Let’s see if I post a negative and honest comment how long it takes for a fake rebuttal. If Rhofade was so great every Derm would know about it and promote it. The silence from dermatologists is deafening

      • Hi Tom,

        It is true that you can not really know who is posting comments – but in general dermatologists don’t post much to online boards.


        • Tom says:


          My 16 year old daughter is having redness issues. I have read ur stuff for years. It’s been helpful.
          How can I DM u?
          I look online for ur email but could not locate it. I would like ur advice to try to help her. She is sad and I have to find a way to help her. Thank u for all u do.

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.